CNV stands for Copy Number Variants, which are segments of DNA that vary in copy number among individuals in a population.
Extensive research has shown the prominence of CNVs in the human genome, with contributions from various studies (Sebat et al., 2007; Szatmari et al., 2007; etc.).
Formation of CNVs
CNVs often arise in genomic regions flanked by Low Copy Repeats (LCR) which are prone to Non-Allelic Homologous Recombination (NAHR).
These events can lead to a recurrent nature of CNVs and are often found as de novo mutations upon inspection.
Risk Genes for Schizophrenia Identified by GWAS
Notable risk genes include:
DISC1 (Chromosome 1)
ZNF804A (Chromosome 2)
NRXN1 (Chromosome 11)
NRGN (Chromosome 8)
TCF4 (Chromosome 22)
MHC (Chromosome 6)
The list includes other genes associated with bipolar disorder and autism spectrum disorders.
De Novo CNVs
Characteristically, these mutations are not inherited from either parent.
Frequency of de novo CNVs:
10% in simplex schizophrenia families.
3% in multiplex schizophrenia families.
<1% in non-disease samples.
Specific large CNVs at chromosomes 1q21.1, 15q11.2, and 15q13.3 correlate with approximately 1% of schizophrenia cases.
Detection of CNV
Techniques
Single-cell Sequencing: Uses Multiple Displacement Amplification (MDA) with hexamer primers for higher fidelity detection of CNVs in single neurons.
Next Generation Sequencing (NGS): Utilizes modern technologies for high-throughput sequencing, enabling the detection of rare mutations and CNVs at a larger scale.
Next Generation Sequencing vs. Sanger Sequencing
Sanger sequencing (1977) uses dideoxynucleotides for chain termination, while NGS implements micro/nanotechnologies to sequence millions of fragments concurrently.
NGS is characterized by:
Highly multiplexed sequencing.
Reduced reagent costs.
Capable of outputting hundreds of millions of DNA reads in a single run.
Multiplexing
This method allows simultaneous analysis of multiple samples through barcoding during library construction, enhancing throughput in sequencing and analysis.
Sequencing Cost Trends
Notable examples include:
The Human Genome Project took 13 years and cost around $3 billion.
Modern techniques have drastically reduced costs, e.g., $10,000 for a genome in just 8 days using Illumina technologies.
Treatment of Schizophrenia
Dopamine Hypothesis
Evidence for dopamine involvement in schizophrenia:
Autopsy studies show increased dopamine receptors.
Weight gain, sexual dysfunction, and seizures (rare).
Atypical Antipsychotics**
CLOZAPINE is effective for treatment-resistant schizophrenia and has minimal extrapyramidal side effects.
OLANZAPINE is known for its multi-receptor action, controlling mood symptoms but associated with weight gain and sedation.
Conclusion - Key Takeaways
Knowledge of DE NOVO mutations, CNVs, and the mechanisms behind drug actions are crucial for treatment approaches in schizophrenia.
Differentiating between typical and atypical antipsychotic treatments can help tailor treatment plans effectively to individual patient needs, addressing both positive and negative symptoms of the disorder.